Company Profile
|
Kazia Therapeutics Limited
(NASDAQ: KZIA)
|
3:59 PM EDT, 09/25/20 | |||
|---|---|---|---|---|
| Last: $6.85 | Change: +0.26 | %Change: +3.95% | Volume: 17,678 | |
Detailed Quote
M = Million B = Billion
Price Performance
Management Effectiveness
Profitability
| Open: | $ 6.65 | Volume: | 17,678 | |
|---|---|---|---|---|
| High: | $ 6.85 | Yield(%) | n/a | |
| Low: | $ 6.58 | P/E Ratio (ttm): | n/a | |
| Dividend ($): | n/a | Market Cap ($): | 54.94M | |
| EPS ($) | n/a | Shares Out: | 80.21M |
| % Price Change (last 4 weeks): | -10.95 |
|---|---|
| % Price Change (last 13 weeks): | 88.83 |
| % Price Change (last 26 weeks): | 119.67 |
| % Price Change (last 52 weeks): | 84.08 |
| % Price Change (year to date): | 51.84 |
| Return on Equity (%): | -84.91 |
|---|---|
| Return on Assets (%): | -54.38 |
| Return on Invested Capital (%): | -47.79 |
| Gross Profit Margin (%): | n/a |
|---|---|
| Net Profit Margin (%): | n/a |
| Operating Profit Margin (%): | 0.00 |
Price & Volume
Company Information
Per Share Data
Valuation Ratios
Financial Strength
|
|
|
| 50-day Moving Average: | $6.04 |
|---|---|
| 200-day Moving Average: | $4.12 |
| Avg. Daily Vol. (last 50 days): | 740,040 |
| Avg. Daily Vol. (last 200 days): | 214,814 |
| 52-wk high: | $9.74 |
| 52-wk low: | $2.47 |
| Bid: | $6.45 |
| Ask: | $7.99 |
|
Kazia Therapeutics Ltd. engages in the pharmaceutical drug research and development. Its pipeline includes two clinical-stage drug development candidates such as GDC-0084, and Cantrixil. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
|
|
Kazia Therapeutics Limited
Three International Towers Level 24 300 Barangaroo Avenue Sydney NS 2000 Phone: n/a Fax: n/a http://www.kaziatherapeutics.com |
| Earnings (1year) ($): | -1.15 |
|---|---|
| Annual Dividend ($): | n/a |
| Current P/E Ratio (ttm): | n/a |
| Book Value ($): | 1.03 |
| Cash Flow ($): | -0.81 |
| Price/Earnings (x): | n/a |
|---|---|
| Price/Sales (x): | n/a |
| Price/Book (x): | 3.30 |
| Price/Cash Flow (x): | n/a |
| Quick Ratio (x): | 1.99 |
|---|---|
| Current Ratio (x): | 1.99 |
| LT Debt/Equity (x): | 0.00 |
| Total Debt/Equity (x): | 0.00 |
